Evidence map›Paper›PMID 35740432›Full record

ArticleBiomedicines2022

A Metabolomic Profiling of Intra-Uterine Growth Restriction in Placenta and Cord Blood Points to an Impairment of Lipid and Energetic Metabolism.

Juan Manuel Chao de la Barca, Floris Chabrun, Tiphaine Lefebvre, Ombeline Roche, Noémie Huetz, Odile Blanchet, Guillaume Legendre, Gilles Simard, Pascal Reynier, Géraldine Gascoin

Abstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Proteomics and Metabolomics in Biomedicine.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Juan Manuel Chao de la BarcaUnité Mixte de Recherche (UMR) MITOVASC, Structure Fédérative de Recherche (SFR) ICAT, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Angers, F-49000 Angers, France.
Floris ChabrunUnité Mixte de Recherche (UMR) MITOVASC, Structure Fédérative de Recherche (SFR) ICAT, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Angers, F-49000 Angers, France.ORCID 0000-0001-6871-8711
Tiphaine LefebvreRéanimation et Médecine Néonatales, Centre Hospitalier Universitaire, F-49000 Angers, France.
Ombeline RocheRéanimation et Médecine Néonatales, Centre Hospitalier Universitaire, F-49000 Angers, France.
Noémie HuetzRéanimation et Médecine Néonatales, Centre Hospitalier Universitaire, F-49000 Angers, France.
Odile BlanchetCentre de Ressources Biologiques, BB-0033-00038, Centre Hospitalier Universitaire, F-49000 Angers, France.ORCID 0000-0002-8275-8741
Guillaume LegendreDépartement de Gynécologie Obstétrique, Centre Hospitalier Universitaire, F-49000 Angers, France.
Gilles SimardService de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire, F-49000 Angers, France.
Pascal ReynierUnité Mixte de Recherche (UMR) MITOVASC, Structure Fédérative de Recherche (SFR) ICAT, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Angers, F-49000 Angers, France.ORCID 0000-0003-0802-4608
Géraldine GascoinUnité Mixte de Recherche (UMR) MITOVASC, Structure Fédérative de Recherche (SFR) ICAT, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Angers, F-49000 Angers, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Intrauterine growth restriction (IUGR) involves metabolic changes that may be responsible for an increased risk of metabolic and cardiovascular diseases in adulthood. Several metabolomic profiles have been reported in maternal blood and urine, amniotic fluid, cord blood and newborn urine, but the placenta has been poorly studied so far. (2) Methods: To decipher the origin of this metabolic reprogramming, we conducted a targeted metabolomics study replicated in two cohorts of placenta and one cohort of cord blood by measuring 188 metabolites by mass spectrometry. (3) Results: OPLS-DA multivariate analyses enabled clear discriminations between IUGR and controls, with good predictive capabilities and low overfitting in the two placental cohorts and in cord blood. A signature of 25 discriminating metabolites shared by both placental cohorts was identified. This signature points to sharp impairment of lipid and mitochondrial metabolism with an increased reliance on the creatine-phosphocreatine system by IUGR placentas. Increased placental insulin resistance and significant alteration of fatty acids oxidation, together with relatively higher phospholipase activity in IUGR placentas, were also highlighted. (4) Conclusions: Our results show a deep lipid and energetic remodeling in IUGR placentas that may have a lasting effect on the fetal metabolism.

Indexed as

cord bloodintra-uterine growth restrictionlipidomicmetabolomicsplacenta

Identifiers

PMID35740432
PMCPMC9220006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.